Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current status and future prospects of molecular hybrids with thiazolidinedione (TZD) scaffold in anticancer drug discovery
Kalpana Tilekar, Onkar Shelke, Neha Upadhyay, et al.
Journal of Molecular Structure (2021) Vol. 1250, pp. 131767-131767
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

4-Thiazolidinone-Bearing Hybrid Molecules in Anticancer Drug Design
Piotr Roszczenko, Serhii Holota, Olga Szewczyk‐Roszczenko, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13135-13135
Open Access | Times Cited: 46
Design, synthesis of new 2,4-thiazolidinediones: In-silico, in-vivo anti-diabetic and anti-inflammatory evaluation
Shankar Gharge, Shankar G. Alegaon, Shriram D. Ranade, et al.
European Journal of Medicinal Chemistry Reports (2024) Vol. 11, pp. 100151-100151
Open Access | Times Cited: 11
3,5-Disubstituted-thiazolidine-2,4-dione hybrids as antidiabetic agents: Design, synthesis, in-vitro and In vivo evaluation
Gurpreet Singh, Rajveer Singh, Vikramdeep Monga, et al.
European Journal of Medicinal Chemistry (2024) Vol. 266, pp. 116139-116139
Closed Access | Times Cited: 10
New Succinimide–Thiazolidinedione Hybrids as Multitarget Antidiabetic Agents: Design, Synthesis, Bioevaluation, and Molecular Modelling Studies
Mohammed Ayed Huneif, Mater H. Mahnashi, Muhammad Saeed Jan, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1207-1207
Open Access | Times Cited: 20
Design, synthesis, characterization and Antidiabetic evaluation of 3,5-substituted thiazolidinediones: Evidenced by network pharmacology, Molecular docking, dynamic simulation, in vitro and in vivo assessment
Shankar Gharge, Shankar G. Alegaon, Swaroop Jadhav, et al.
European Journal of Medicinal Chemistry Reports (2024) Vol. 12, pp. 100213-100213
Open Access | Times Cited: 8
Synthesis, Anticancer Activity and Molecular Docking Studies of Hybrid Molecules Containing Indole‐Thiazolidinedione‐Triazole Moieties
Nagaraju Perike, Praveen Kumar Edigi, Nirmala Gurrapu, et al.
ChemistrySelect (2022) Vol. 7, Iss. 47
Closed Access | Times Cited: 21
Expanding the potential of pyridine scaffold for targeted therapy of cancer: Biological activity, Molecular insights, and Structure-activity relationship
Nimmagadda Venkata Satya Sai Aishwarya, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
Journal of Molecular Structure (2024) Vol. 1321, pp. 139655-139655
Closed Access | Times Cited: 4
Synthesis, single crystal XRD, in vitro evaluation, molecular docking and ADMET studies of cuminaldehyde-thiazolidine-2,4-dione hybrids as potential α-glucosidase inhibitors
Abhik Paul, Sai Satyaprakash Mishra, Arnab Sarkar, et al.
Journal of Molecular Structure (2025), pp. 141510-141510
Closed Access
5-Ene-2-Arylaminothiazol-4(5h)-Ones Induce Apoptosis in Breast Cancer Cell
Rostyslav Dudchak, M Podolak, Ivan Sydorenko, et al.
(2025)
Closed Access
Thiazolidinedione derivatives: emerging role in cancer therapy
Ganesh Latambale, Kapil Juvale
Molecular Diversity (2025)
Closed Access
New phenylpiperazine-thiazolidine-2,4-dione hybrids targeting MAO inhibition: Synthesis, biological evaluation, kinetic study and in silico insights
Lamiaa O. El-Halaby, Mohammad M. Al‐Sanea, Abdullah A. Elgazar, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 121, pp. 118123-118123
Closed Access
The anti-cancer effectiveness of some heterocyclic compounds containing sulfur atom
Hasan Tuhmaz Hamad
Results in Chemistry (2025), pp. 102182-102182
Open Access
Synthesis and Evaluation of Thiazolidinone-Isatin Hybrids for Selective Inhibition of Cancer-Related Carbonic Anhydrases
Alessia Onali, Erica Sanna, Antonio Lupia, et al.
ACS Medicinal Chemistry Letters (2025)
Open Access
Synthesis of thiazolidinone-triazole hybrid compounds as anticancer agents and molecular modeling study
Ahmad Fawzi Qarah, Khadra B. Alomari, Renad Almughathawi, et al.
Journal of Molecular Structure (2025), pp. 142570-142570
Closed Access
Hyperglycemia-driven signaling bridges between diabetes and cancer
Somayyeh Ghareghomi, Payam Arghavani, Majid Mahdavi, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116450-116450
Closed Access | Times Cited: 3
Design, synthesis, and in vitro and in silico study of 1-benzyl-indole hybrid thiosemicarbazones as competitive tyrosinase inhibitors
Zahra Batool, Naeem Ullah, Ajmal Khan, et al.
RSC Advances (2024) Vol. 14, Iss. 39, pp. 28524-28542
Open Access | Times Cited: 3
Thiazolidine-2,4-dione hybrids as dual alpha-amylase and alpha-glucosidase inhibitors: design, synthesis, in vitro and in vivo anti-diabetic evaluation
Gurpreet Singh, Rajveer Singh, Vikramdeep Monga, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 8, pp. 2826-2854
Closed Access | Times Cited: 3
Investigation of the Antifungal and Anticancer Effects of the Novel Synthesized Thiazolidinedione by Ion-Conductance Microscopy
Nikita Savin, Alexander S. Erofeev, Roman V. Timoshenko, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1666-1666
Open Access | Times Cited: 7
An insight into thymidylate synthase inhibitor as anticancer agents: an explicative review
Aratrika Sen, Dipanjan Karati
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 8, pp. 5437-5448
Closed Access | Times Cited: 2
Potential of covalently linked tamoxifen hybrids for cancer treatment: recent update
Devendra Singh Negi, Irshad Ahmad, Donna J. Nelson, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 6, pp. 1877-1898
Closed Access | Times Cited: 2
Exploring Thiazolidine-2,4-dione Derivatives as Privileged Scaffolds for Targeted Anticancer Agents: Biological Activity and Structure-Activity Relationship (SAR) Insights
Mayavan Viji, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
Journal of Molecular Structure (2024), pp. 140529-140529
Closed Access | Times Cited: 2
Novel Thiazolidine-2,4-dione-trimethoxybenzene-thiazole Hybrids as Human Topoisomerases Inhibitors
Maria Stefania Sinicropi, Jessica Ceramella, Patrice Vanelle, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 946-946
Open Access | Times Cited: 6
Thiazolidinedione-Based Structure Modification of Celastrol Provides Thiazolidinedione-Conjugated Derivatives as Potent Agents against Non-Small-Cell Lung Cancer Cells through a Mitochondria-Mediated Apoptotic Pathway
Xuefeng Fu, Qing Mao, Bing Zhang, et al.
Journal of Natural Products (2022) Vol. 85, Iss. 4, pp. 1147-1156
Closed Access | Times Cited: 9
Therapeutic significance of molecular hybrids for breast cancer research and treatment
Devendra Singh Negi, Irshad Ahmad
RSC Medicinal Chemistry (2022) Vol. 14, Iss. 2, pp. 218-238
Open Access | Times Cited: 8
Diabetes Driven Oncogenesis and Anticancer Potential of Repurposed Antidiabetic Drug: A Systemic Review
Iqra Khan, Aisha Kamal, Salman Akhtar
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 3, pp. 1907-1929
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top